Skip to main content
NUS
NYSE Trade & Services

Nu Skin Q3 Revenue $311M, Down 14.6%; Guides Q4 to $310-340M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Negative
Importance info
7
Price
$4.4
Mkt Cap
$220.505M
52W Low
$4.445
52W High
$11.67
52W Position info
1.0% below low
Off High info
62% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

NUS is trading near its 52-week low of $4.445 (1.0% below the low).

Summary

Nu Skin reported Q3 revenue of $311.0M, down 14.6% year over year but within guidance, with adjusted EPS of $0.10 versus $0.34 a year ago. Q4 guidance of $310-340M implies continued double-digit declines.


Key Events · Earnings and Guidance · NUS

  • Q3 Revenue $311.0M, Down 14.6%

    Revenue of $311.0 million fell 14.6% from $364.2 million a year ago, with a 1.1% FX drag, but landed within the company's guidance range.

  • Margins Compress Sharply

    Gross margin dropped to 65.0% from 70.5% and operating margin to 1.6% from 5.9%; adjusted EPS was $0.10 versus $0.34 a year ago.

  • Customer Base Shrinks 18%

    Customers fell 18% to 609,469, paid affiliates 10% to 116,449 and sales leaders 13% to 26,995, signaling the revenue decline may persist.

  • Q4 Guidance $310-340M

    Management guided Q4 revenue to $310-340 million, implying a decline of 8-16%, with EPS of $0.05-0.15 or $0.11-0.21 adjusted.


Analysis · NUS · Trade & Services

Revenue landed inside guidance, but the top line is still shrinking at a double-digit pace and profitability has nearly evaporated: gross margin fell to 65.0% from 70.5% and operating margin to 1.6% from 5.9%. The customer base is contracting faster than revenue — customers down 18% and sales leaders down 13% — which points to further pressure before any stabilization. Management's Q4 guide of $310-340M implies continued declines of 8-16%, and the full-year adjusted EPS range of $0.55-0.65 is a fraction of prior-year profitability. With the stock near its 52-week low, the market is pricing in skepticism that the holiday-season sequential growth the CEO expects will materialize.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NUS was trading at $4.40 on NYSE in the Trade & Services sector, with a market capitalization of approximately $220.5M. The 52-week trading range was $4.45 to $11.67. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NUS - Latest Insights

NUS
Nov 05, 2026, 7:34 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.10
Real-time Price: $3.87 info
Change: -$0.2285 (-6%) info
Market Cap: $183.516M info
NUS
Nov 05, 2026, 4:06 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $4.53
Real-time Price: $3.87 info
Change: -$0.6585 (-15%) info
Market Cap: $183.516M info
NUS
Aug 10, 2026, 5:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.57
Real-time Price: $3.87 info
Change: -$0.6985 (-15%) info
Market Cap: $183.516M info
NUS
Aug 10, 2026, 4:26 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $4.47
Real-time Price: $3.87 info
Change: -$0.5985 (-13%) info
Market Cap: $183.516M info
NUS
Aug 10, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.48
Real-time Price: $3.87 info
Change: -$0.604 (-13%) info
Market Cap: $183.516M info